Table 3 Anthropometric data, obesity indexes, and prevalence of obesity-related diseases in the total sample, and the comparison between periodontitis and non-periodontitis groups
Parameter | Data | All patients (N = 79) | Periodontitis group (N = 51) | Non-periodontitis group (N = 28) | Periodontitis vs non-periodontitis groups; p value |
|---|---|---|---|---|---|
Waist circumference (cm) | Mean | 130.2 | 130.9 | 128.9 | 0.41† |
SD | 16.2 | 15 | 17 | ||
BMI (kg/m2) | Mean | 44.6 | 44.5 | 44.5 | 0.96† |
SD | 7.2 | 6.7 | 9 | ||
BMI > 40 | 71% | 71% | 71% | 1‡ | |
BMI 35–39.9 | 29% | 29% | 29% | ||
EOSS stage (% of patients) | 0 | 1% | 0% | 3.5% | 0.228‡ |
1 | 6% | 4% | 11% | ||
2 | 44% | 45% | 43% | ||
3 | 44% | 49% | 35.5% | ||
4 | 4% | 2% | 7% |
Disease | All patients prevalence (95% CI) | Periodontitis group prevalence (95% CI) | Non-periodontitis group prevalence (95% CI) | Periodontitis vs non-periodontitis groups; p value |
|---|---|---|---|---|
Diabetes mellitus | 35% (24–46) | 35% (22–50) | 32% (16–52) | 0.809‡ |
Hypercholesteremia | 31% (21–42) | 33% (21–48) | 29% (13–49) | 0.801‡ |
Hypertriglyceridemia | 20% (12–31) | 16% (7–29) | 25% (11–45) | 0.373‡ |
Dyslipidaemia | 35% (25–47) | 35% (22–50) | 36% (19–56) | 0.82‡ |
Hypertension | 60% (49–71) | 73% (58–84) | 36% (19–56) | 0.00193*‡ |
Obstructive sleep apnoea | 44% (33–56) | 47% (33–62) | 39% (22–59) | 0.63‡ |
Depression | 17% (10–27) | 18% (8–31) | 18% (6–37) | 1‡ |
Orthopaedic disorders | 69% (58–79) | 75% (60–86) | 61% (41–78) | 0.213‡ |
PCOS (% of females) | 15% (5–20) | 11% (2–19) | 23% (6–37) | 0.384‡ |
Other diseases | 62% (50–72) | 68% (54–81) | 50% (31–69) | 0.145‡ |
Metabolic syndrome | 43% (32–55) | 45% (31–60) | 39% (22–59) | 0.643‡ |